Phase IIb BID Results Recap In June 2025, MDR-001 BID dosing regimen achieved primary endpoints in the Phase IIb clinical trial, the results demonstrated that MDR-001 achieved a weight loss of up to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback